Fierce Pharma reported according to data from Standard Media Index (SMI), pharma ad spend on linear TV fell by 4% YoY in 2022 while digital’s share of the media mix rose from 49.6% to 52.6%, marking a possible tipping point in the transition to digital pharma advertising.
“There has been a little bit of a replacement of ad spending dollars on TV with digital. TV is still massive, in our pool it represents $5 billion, which is a huge amount of spend by pharmaceutical advertising, but we've started to see in the last year that the shift is a little bit more pronounced,” Darrick Li, vice president of sales in North America at SMI, said. “It's pretty phenomenal that we're seeing that shift happen so quickly.”
Trends in Continuing Medical Education
April 12th 2024Elliott Yoo, Senior Media Strategist at epocrates, takes a closer look at the trends in CME consumption and what the future of medical education will be – from the priorities for physicians as they juggle learning with patient care, to what type of activities resonate most with prescribers.
Transforming Cancer Care: Data, AI, and Patient-Centered Care
July 20th 2023Join us as Mohit Manrao, SVP and head of US oncology at AstraZeneca, shares his patient-centered approach to transforming cancer care, bridging the gap between innovative science and tangible patient outcomes across all populations on a global scale.